PHAR 401 Parenteral Administration Quiz
10 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the main advantage of subcutaneous (SC) administration over intravenous (IV) administration?

  • Reduced risk of bloodstream infection (correct)
  • Faster and complete absorption
  • Lower healthcare costs
  • Less pharmaceutical preparation required
  • Why does subcutaneous (SC) administration allow smaller dose size?

  • Reduced risk of necrosis
  • Complete absorption into the bloodstream
  • Avoidance of first pass metabolism (correct)
  • Faster injection process
  • What is a significant disadvantage of subcutaneous (SC) administration?

  • Risk of local tissue reactions/hypersensitivity (correct)
  • Higher patient compliance
  • Need for a hospital setting
  • Rapid and complete absorption
  • Why is subcutaneous (SC) administration considered more convenient for patients and medical staff?

    <p>Requires less pharmaceutical preparation</p> Signup and view all the answers

    How does subcutaneous (SC) administration contribute to reducing costs for the healthcare system?

    <p>Requires less pharmaceutical preparation</p> Signup and view all the answers

    What is the driving force for interstitial flow in the absorption pathway of the subcutaneous route?

    <p>Osmotic differences among blood, interstitium, and lymphatics</p> Signup and view all the answers

    In convective transport in the absorption pathway for small peptides and proteins administered subcutaneously, what is NOT a limiting factor for molecular size?

    <p>Diffusion through the ECM</p> Signup and view all the answers

    Why is subcutaneous administration frequently considered more immunogenic than intravenous administration?

    <p>Presence of dendritic and langerhans cells in the hypodermis</p> Signup and view all the answers

    What is a potential limitation of subcutaneous route for peptide/protein therapeutics related to bioavailability?

    <p>Variable thickness of the hypodermis in humans</p> Signup and view all the answers

    Why may the immunogenicity of biologics after subcutaneous administration decrease compared with intradermal administration?

    <p>Presence of antigen-presenting cells mainly in the hypodermis</p> Signup and view all the answers

    More Like This

    PHAR 505 Fall 2022-2023: Mechanism of Action
    21 questions
    PHAR 4813
    61 questions

    PHAR 4813

    GenerousGradient8671 avatar
    GenerousGradient8671
    Use Quizgecko on...
    Browser
    Browser